About OriGENE
OriGENE is a Dutch organisation specialised in the treatment of back pain. Based on practical experience and research, we have developed and optimised OriGENE back therapy and the corresponding treatment device (the OriGENE 1). We use a lab test room for this purpose. We also share experiences and insights with all our OriGENE practitioners. Thanks to our extensive knowledge about-and experience with-the treatment of back pain, we are a knowledge institute where practice, research and science come together. Based on this, we also recently developed a treatment method for neck and (high) back pain; the OriGENE TS 2.3, or OriGENE2. This was granted a European patent in 2016.
The emergence of the
OriGENE treatment method
Mission
With a high-quality and leading treatment concept, OriGENE aims to cure or prevent lower back complaints. In an honourable, responsible, sustainable and economically sound manner. OriGENE considers its practice-based approach of great importance and also wants to stimulate evidence-based care within physiotherapy by initiating scientific research. In this way, OriGENE wants to contribute to:
- a substantial improvement in people's health and quality of life
- the manageability of healthcare costs
- an improvement in labour productivity
Expansion of locations
From 2005, the OriGENE concept became available at an increasing number of treatment locations. There are now over 100 treatment locations in the Netherlands, Germany and Switzerland. In cooperation with these treatment locations, the treatment protocols were further tested, including by analysing the treatment of people who did not immediately respond optimally to the treatment concept: the non-responders. Individual adjustments in the adjustment of the device, the treatment programme or in the combination with other exercises often lead to the expected success for these non-responders.
Research
For several years, scientific research on the OriGENE method has been taking place in various locations. Practical experiences from the nearly 100 OriGENE branches in the Netherlands guide the research that OriGENE initiates. Research is carried out by various research groups, training institutes and universities. Read more about scientific research. Qualitative research also took place in the form of focus group discussions with treated patients. A report of this patient survey has been published. Want to know more? Go to: Patient survey. For a current list of OriGENE practitioners, please visit treatment locations.
Experience back treatments
Over the years, extensive practical experience has been gained with tens of thousands of previously often difficult-to-treat patients, including a considerable number of elite athletes. During the test period, the treatment device and the subsequent treatment programmes were continuously evaluated and adjusted in details according to the experience gained. The vast majority of patients, including chronic and initially therapy-resistant patients, are symptom-free with OriGENE.
Technical specifications
De Origene1 en Origene2- Behandeltoestellen ®℗™ zijn zgn. Medical Devices en vallen onder de MDR (Medical Device Regulation), Class I, MDR EU 2017/745.
OriGENE is als zodanig aangemeld bij de bevoegde autoriteiten onder SRN: NL-MF-000010794 en de beide behandeltoestellen zijn geregistreerd in Eudamed onder de volgende registratienummers:
OriGENE 1 | O1 | 8720648272004 |
OriGENE 2 | O2 | 8720648272011 |
De afgegeven Declaration of Conformity is geldig tot 3 juli 2031.
In addition, various other regulations apply, including :
– OHIM (Office for Harmonisation in the Internal Market) reg. Number 0003691656 en reg. Number 000135827
– Benelux Merken Bureau inschrijvingsnummers 0732076 en 0718104
– (internationale) Octrooien met octrooinummer 2008524 en octrooinummer 2644230.
– En andere.
More information on this and the technical specifications of the devices can be found at here find.